Armata Pharmaceuticals, Inc. (ARMP): Free Cash Flow
-$26.30M
Year ended 2025-12-31
-$25.79M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$26.30M | n/m | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | -$39.43M | n/m | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | -$55.57M | n/m | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | -$34.69M | n/m | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | -$24.88M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$19.09M | n/m | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | -$15.81M | n/m | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | -$11.50M | n/c | 2020-03-19, From 2018-01-01 |
| 2017-12-31 | -$9.25M | n/m | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | -$10.88M | n/a | 2018-03-14, From 2016-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | -$26.30M | n/m |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | -$20.67M | n/m |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | -$13.63M | n/m |
| Aligos Therapeutics, Inc. (ALGS) | 2024-12-31 | -$80.87M | n/m |
| LeonaBio, Inc. (LONA) | 2024-12-31 | -$97.20M | n/m |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | -$62.06M | n/m |
| Quince Therapeutics, Inc. (QNCX) | 2025-12-31 | -$41.78M | n/m |
| Elutia Inc. (ELUT) | 2025-12-31 | -$46.69M | n/m |
| Passage BIO, Inc. (PASG) | 2024-12-31 | -$47.99M | n/a |
Compare ARMP, ACOG, PLX, ALGS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗